While there was a positive trend in 2-year and 5-year OS and EFS in all age groups, the biggest improvement was seen in patients >70 with a 2-year EFS improving 33.6%, from 35.3% in the 1998–2007 time period to 69.1% in 2017–2021 and the 5-year OS improving 27.6% from 38.6 in 1998–2007 to 66.16% after 2017.
← all excerpts
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma.
1
—
—